Proteome Sciences PLC (PRM) — Cash Flow-to-Debt Ratio
Proteome Sciences PLC (PRM) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of GBX851.00K could theoretically repay 0% of its total liabilities (GBX17.79 Million) in one year. See PRM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Proteome Sciences PLC Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for Proteome Sciences PLC across 31 annual periods. Also explore Proteome Sciences PLC annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Proteome Sciences PLC (1994–2025)
Year-by-year debt coverage analysis for Proteome Sciences PLC. For market capitalisation and broader financial context, see Proteome Sciences PLC (PRM) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | GBX-46.00K | GBX17.79 Million | ▲ +95.1% |
| 2024 | -0.05x | GBX-826.00K | GBX15.72 Million | ▼ -58.6% |
| 2023 | -0.03x | GBX-481.00K | GBX14.52 Million | ▼ -2235443.5% |
| 2022 | 0.00x | GBX2.14 Million | GBX1.44 Trillion | ▲ +145.5% |
| 2021 | 0.00x | GBX793.00K | GBX1.31 Trillion | ▼ -51.1% |
| 2020 | 0.00x | GBX1.58 Million | GBX1.28 Trillion | ▲ +100.0% |
| 2019 | -0.02x | GBX-21.45 Billion | GBX1.07 Trillion | ▼ -44.5% |
| 2018 | -0.01x | GBX-14.78 Billion | GBX1.07 Trillion | ▼ -126.6% |
| 2017 | 0.05x | GBX55.47 Billion | GBX1.07 Trillion | ▲ +119.5% |
| 2016 | -0.27x | GBX-31.70 Billion | GBX119.08 Billion | ▼ -701.7% |
| 2015 | 0.04x | GBX46.63 Billion | GBX1.05 Trillion | ▲ +1012.0% |
| 2014 | 0.00x | GBX-6.27 Billion | GBX1.29 Trillion | ▲ +46.3% |
| 2013 | -0.01x | GBX-11.55 Billion | GBX1.28 Trillion | ▲ +97.9% |
| 2012 | -0.43x | GBX-3.35 Million | GBX7.72 Million | ▲ +36.0% |
| 2011 | -0.68x | GBX-5.17 Million | GBX7.61 Million | ▼ -242.1% |
| 2010 | 0.48x | GBX4.00 Million | GBX8.38 Million | ▲ +348.2% |
| 2009 | -0.19x | GBX-2.97 Million | GBX15.44 Million | ▲ +43.6% |
| 2008 | -0.34x | GBX-4.12 Million | GBX12.07 Million | ▲ +26.6% |
| 2007 | -0.47x | GBX-4.09 Million | GBX8.80 Million | ▲ +50.9% |
| 2006 | -0.95x | GBX-3.61 Million | GBX3.81 Million | ▲ +65.8% |
| 2005 | -2.77x | GBX-4.77 Million | GBX1.72 Million | ▼ -12.9% |
| 2004 | -2.45x | GBX-3.77 Million | GBX1.54 Million | ▼ -29.8% |
| 2003 | -1.89x | GBX-4.88 Million | GBX2.58 Million | ▼ -14.4% |
| 2002 | -1.65x | GBX-3.27 Million | GBX1.98 Million | ▼ -31.5% |
| 2001 | -1.26x | GBX-1.55 Million | GBX1.24 Million | ▼ -73.3% |
| 2000 | -0.72x | GBX-1.14 Million | GBX1.57 Million | ▲ +59.7% |
| 1999 | -1.80x | GBX-1.25 Million | GBX697.00K | ▼ -0.5% |
| 1998 | -1.79x | GBX-1.54 Million | GBX862.00K | ▲ +23.3% |
| 1997 | -2.33x | GBX-1.29 Million | GBX551.00K | ▲ +61.1% |
| 1996 | -6.01x | GBX-1.71 Million | GBX285.00K | ▼ -410.9% |
| 1994 | -1.18x | GBX-809.00K | GBX688.00K | — |